top of page

CHO-K1/Human GPR39 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0244A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


GPR39 is a G protein-coupled receptor (GPCR) widely recognized as a key zinc ion (Zn²⁺) sensor . It is broadly expressed in the pancreas, gastrointestinal tract, liver, adipose tissue, and the central nervous system (e.g., cerebral cortex, hippocampus, and amygdala) . Its primary function is to mediate Zn²⁺ signaling, participating in the regulation of various physiological processes such as insulin secretion, gastrointestinal motility, epithelial repair, neuronal function, and anti-inflammatory responses . Dysregulation of GPR39 is associated with diseases including diabetes, depression, obesity, and certain cancers, making it a potential therapeutic target .

 

Screeningbio’s CHO-K1/Human GPR39 cell line overexpress GPR39 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

GPR39

Accession Number

NM_001508 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Human GPR39 Agonist Assay. CHO-K1/Human GPR39 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human GPR39 Agonist Assay. CHO-K1/Human GPR39 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


GPR39 is a G protein-coupled receptor (GPCR) widely recognized as a key zinc ion (Zn²⁺) sensor . It is broadly expressed in the pancreas, gastrointestinal tract, liver, adipose tissue, and the central nervous system (e.g., cerebral cortex, hippocampus, and amygdala).


Its primary function is to mediate Zn²⁺ signaling, participating in the regulation of various physiological processes such as insulin secretion, gastrointestinal motility, epithelial repair, neuronal function, and anti-inflammatory responses.


Dysregulation of GPR39 is associated with diseases including diabetes, depression, obesity, and certain cancers, making it a potential therapeutic target.

 



Product Documentation



bottom of page